Arterial Wall Neovascularization — Potential Role in Atherosclerosis and Restenosis—

Japanese Circulation Journal

Volumn 61, Issue 11, 1997, Pages 893-904

  Pels, Klaus ^a   Labinaz, Marino ^a   O'Brien, Edward R ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Coronary artery disease; Neovascularization; Remodeling; Restenosis

Indexed keywords

ARTERIAL PRESSURE; ARTERY BLOOD FLOW; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; ENDOTHELIUM INJURY; HEMODYNAMICS; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; RESTENOSIS; REVIEW;

ARTERIES; ARTERIOSCLEROSIS; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; HUMANS; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; RECURRENCE; VASA VASORUM;

EID: 0030668567     PISSN: 00471828     EISSN: None     Source Type: Journal    
DOI: 10.1253/jcj.61.893     Document Type: Article

References (131)

1. O'Brien E. R., Schwartz S. M.: Update on the biology and clinical study of restenosis. Trends Cardiovasc Med 1994; 4: 169-178.
2. Isner J. M.: Vascular remodeling: Honey, I think I shrunk the artery. Circulation 1994; 89: 2937-2941.
3. Gordon D., Reidy M. A., Benditt E. P., Schwartz S. M.: Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990; 87: 4600-4604.
4. O'Brien E. R., Alpers C. E., Stewart D. K., Ferguson M., Tran N., Gordon D., et al: Proliferation in primary and restenotic coronary atherectomy tissue: Implications for anti-prolifera-tive therapy. Circ Res 1993; 73: 223-231.
5. Koester W.: Endarteritis and arteriitis. Bed Klin Wochenschr 1876; 13: 454-455.
6. Barker S. G., Talbert A., Cottam S., Baskerville P. A., Martin J. F.: Arterial intimal hyperplasia after occlusion of the adventitial vasa vasorum in the pig. Arterioscler Thromb 1993; 13: 70-77.
7. Stefanidis C., Vlachopoulos C., Karayannacos P., Boudoulas H., Stratos C., Filippides T., et al: Effect of vasa vasorum flow on structure and function of the aorta in experimental animals. Circulation 1995; 91: 2669-2678.
8. Wagner R. C.: Endothelial cell embryology and growth. Adv Microcirc 1980; 9: 45-75.
9. Risau W., Sariola H., Zerwes H. G., Sasse J., Ekblom P., Kemler R., et al: Vasculogenesis and angiogenesis in embryonic stem cell derived embryoid bodies. Development 1988; 102:471-478.
10. Pardanaud L., Yassine F., Dieterlenlievre F., Buck C. A.: Relationship between vasculogenesis, angiogenesis and hematopoiesis during avian ontogeny. Development 1989; 105: 473-485.
11. Plate K. H., Breier G., Risau W.: Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994; 4: 207-218.
12. Folkman J.: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995; 1: 27-31.
13. LeLievre C. S., Le Douarin N. M.: Mesenchymal derivatives of the neural crest: Analysis of chimaeric quail and chick embryos. J Embryol Exp Morphol 1975; 34: 125-154.
14. Ekblom P., Sariola H., Karkinen-Jaaskelainen M., Saxeb L.: The origin of the glomerular endothelium. Cell Different 1982; 11: 35-39.
15. Kumamoto M., Nakashima Y., Sueishi K.: Intimal neovascularization in human coronary atherosclerosis: Its origin and pathophysiological significance. Hum Pathol 1995; 26: 450-456.
16. Zamir M., Silver M. D.: Vasculature in the walls of human coronary arteries. Arch Pathol Lab Med 1985; 109: 659-662.
17. Clarke J. A.: An x-ray microscopic study of the postnatal development of the vasa vasorum in the human aorta. J Anat 1965; 99: 877-889.
18. Tannock I. F., Hayashi S.: The proliferation of capillary endothelial cells. Cancer Res 1972; 32: 77-82.
19. Spaet T. H., Lejnieks I.: Mitotic activity of rabbit blood vessels. Proc Soc Exp Biol Med 1967; 125: 1197-1201.
20. Florentin R. A., Nam S. C., Lee K. T., Thomas W. A.: Increased 3H-thymidine incorporation into endothelial cells of swine fed cholesterol for 3 days. Exp Mol Pathol 1969; 10: 250-255.
21. Payling-Wright H.: Endothelial turnover. Thromb Diath Haemorrh 1970; 40(Suppl): 79-84.
22. Gaynor E.: Increased mitotic activity in rabbit endothelium after endotoxin. An autoradiographic study. Lab Invest 1971; 24: 318-320.
23. O'Brien E. R., Garvin M. R., Dev R., Stewart D. K., Hinohara T., Simpson J. B., et al: Angiogenesis in human coronary atherosclerotic plaques. Am J Pathol 1994; 145: 883-894.
24. Pels K., Labinaz M., Garvin M. R., Hoffert C., O'Brien E. R.: Arterial wall neovascularization after balloon injury: Relationship to luminal area (abstract). Can J Cardiol 1996; 12: 148E
25. Winternitz M. C., Thomas R. M., LeCompte P. M.: The biology of arteriosclerosis. Springfield: Charles C. Thomas: 1938.
26. Geiringer E.: Intimal vascularization and atherosclerosis. J Pathol Bacteriol 1951; 63: 201-211.
27. Barger A. C., Beeuwkes R., Lainey L. L., Silverman K. J.: Hypothesis: Vasa vasorum and neovascularization of human coronary arteries. TV Engl J Med 1984; 310: 175 - 177.
28. Heistad D. H., Armstrong M. L.: Blood flow through vasa vasorum of coronary arteries in atherosclerotic monkeys. Arteriosclerosis 1986; 6: 326-331.
29. Williams J. K., Armstrong M. L., Heistad D. D.: Vasa vasorum in atherosclerotic coronary arteries: Responses to vasoactive stimuli and regression of atherosclerosis. Circ Res 1988; 62: 515-523.
30. Zhang Y., Cliff W. J., Schoefl G. I., Higgins G.: Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am J Pathol 1993; 143: 164-172.
31. Zollikofer C. L., Redha F. H., Bruhlmann W. F., Uhlschmid G. K., Vlodaver Z., Castaneda-Zuniga W. R., et al: Acute and long-term effects of massive balloon dilation on the aortic wall and vasa vasorum. Radiology 1987; 164: 145-149.
32. Nobuyoshi M., Kimura T., Ohishi H., Horiuchi H., Nosaka H., Hamasaki N., et al: Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J Am Coll Cardiol 1991; 17: 433-439.
33. Nakata Y, Shionoya S.: Vascular lesions due to obstruction of the vasa vasorum. Nature 1966; 212: 1258-1259.
34. Booth R. F., Martin J. F., Honey A. C., Hassall D. G., Beesley J. E., Moncada S.: Rapid development of atherosclerotic lesions in the rabbit carotid artery induced by perivascular manipulation. Atherosclerosis 1989; 76: 257-268.
35. Barker S. G., Tilling L. C., Miller G. C., Beesley J. E., Fleetwood G, Stavri G. T., et al: The adventitia and atherogenesis: Removal initiates intimal proliferation in the rabbit which regresses on generation of a ‘neoadventitia ’. Atherosclerosis 1994; 105: 131-144.
36. Folkow B.: ‘Structural factor ’ in primary and secondary hypertension. Hypertension 1990; 16: 89 - 101.
37. Glagov S, Weisenberg E, Zarins C. K., Stankunavicius R, Kolettis G. J.: Compensatory enlargement of human atherosclerotic coronary arteries. TV Engl J Med 1987; 316: 1371-1375.
38. Kakuta T, Currier J. W., Haudenschild C. C., Ryan T. J., Faxon D. P.: Differences in compensatory vessel enlargement, not intimal formation, account for restenosis following angioplasty in the hypercholesterolemic rabbit model. Circulation 1994; 89: 2809-2815.
39. Andersen H. R., Maeng M, Thorwest M, Falk E.: Remodeling rather than neointimal formation explains luminal narrowing after deep vessel wall injury. Insights from a porcine (re)stenosis model. Circulation 1996; 93: 1716-1724.
40. Mintz G. S., Popma J. J., Pichard A. D., Kent K. M., Satler L. F., Wong S. C., et al: Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study. Circulation 1996; 94: 35-43.
41. Dvorak H. F., Harvey V. S., Estrella P, Brown L. F., McDonagh J, Dvorak A. M.: Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 1987; 57: 673-686.
42. Hunt T. K., Knighton D. R., Thakral K. K., Goodson W. H., Andrew W. S.: Studies on inflammation and wound healing: Angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophage. Surgery 1984; 96: 48-54.
43. Dvorak H. F.: Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. JV Engl J Med 1986; 315: 1650-1659.
44. Gailit J, Clark R. A. F.: Wound repair in the context of extracellular matrix. Curr Opin Cell Biol 1994; 6: 717-725.
45. Scott N. A., Cipolla G. D., Ross C. E., Dunn B, Martin F. H., Simonet L, et al: Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries. Circulation 1996; 93: 2178-2187.
46. Shi Y., Pieniek M., Fard A., O'Brien J., Mannion J. D., Zalewski A.: Adventitial remodeling after coronary artery injury. Circulation 1996; 93: 340-348.
47. Shi Y, O'Brien J, Fard A, Mannion J. D., Wang D, Zalewski A.: Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996; 94: 1655-1664.
48. O'Brien E. R., Garvin M. R., Pels K, Labinaz M.: Molecular insights into vascular narrowing: Mediators of arterial remodeling and neointimal formation (abstract). Jpn Circ J 1996; 60: 534.
49. Shi Y, O'Brien J, Fard A, Zalewski A.: Transforming growth factor-β1 expression and myofibroblast formation during arterial repair, Arterioscler Thromb Vase Biol 1997; 16: 1298-1305.
50. Jurrus E. R., Weiss H. S.: In vitro tissue oxygen tensions in the rabbit aortic arch. Atherosclerosis 1977; 28: 223-232.
51. Zemplenyi T., Crawford D. W., Cole M. A.: Adaptation to arterial wall hypoxia demonstrated in vivo with oxygen microcathodes. Atherosclerosis 1989; 76: 173 - 179.
52. Helfman T., Falanga V.: Gene expression in low oxygen tension. Am J Med Sci 1993; 306: 37-41.
53. Kourembanas S, Hannan R. L., Faller D. V.: Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells. J Clin Invest 1990; 86: 670-674.
54. Kourembanas S., Marsden P. A., McQuillan L. P., Faller D. V.: Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991; 88: 1054-1057.
55. Namiki A., Brogi E., Kearney M. A., Kim E. A., Wu T., Couf-finhal T., et al: Hypoxia induces vascular endothelial cell growth factor in cultured human endothelial cells. J Biol Chem 1995; 270: 31189-31195.
56. Brogi E., Wu T., Namiki A., Isner J. M.: Indirect angiogenic cytokines upregulate VEGF and bFGF in vascular smooth muscle cells, whereas hypoxia up regulates VEGF expression only. Circulation 1994; 90: 649-652.
57. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., et al: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-439.
58. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K. S., et al: Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380: 439-442.
59. Breier G., Albrecht U., Sterrer S., Risau W.: Expression of vascular endothelial growth factor during embryogenic angiogenesis and endothelial cell differentiation. Development 1992; 114:521-532.
60. Keck P. J., Hauser S. D., Krivi G., Sanzo K., Warren T., Feder J., et al: Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-1312.
61. Dvorak H. F., Brown L. F., Detmar M., Dvorak A. M.: Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995; 146: 1029-1039.
62. Senger D. R., Ledbetter S. R., Claffey K. P., Papadopoulos-Sergiou A., Perruzzi C. A., Detmar M.: Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the αvβ3 integrin, osteopontin, and thrombin. Am J Pathol 1996; 149: 293-305.
63. Senger D. R.: Molecular framework for angiogenesis. A complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am J Pathol 1996; 149: 1-7.
64. Pepper M. S., Ferrara N., Orci L., Montesano R.: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992; 189: 824-831.
65. Plate K. H., Breier G., Weich H. A., Risau W.: Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-848.
66. Brown L. F., Yeo K. T., Berse B., Yeo T. K., Senger D. R., Dvorak H. F., et al: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992; 176: 1375-1379.
67. Shweiki D., Itin A., Soffer D., Keshet E.: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-845.
68. Olofsson B., Pajusola K., Kaipainen A., Von Euler G., Joukov V., Saksela O., et al: Vascular endothelial growth factor B., a novel growth factor for endothelial cells. Proc Natl Acad Sci USA 1996; 93: 2576-2581.
69. Olofsson B., Pajusola K., Von Euler G., Chilov D., Alitalo K., Eriksson U.: Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. J Biol Chem 1996; 271: 19310-19317.
70. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., et al: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290-298.
71. Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., Persico M. G.: Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci USA 1991; 88: 9267-9271.
72. Park J. E., Chen H. H., Winer J., Houck K. A., Ferrara N.: Placenta growth factor. Potentiation of vascular growth factor bioactivity, in vitro and in vivo, and high affinity binding to flt-1 but not to flk-1/KDR. J Biol Chem 1994; 269: 25646-25654.
73. Montesano R., Vassalli J. D., Baird A., Guillemin R., Orci L.: Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986; 83: 7297-7301.
74. Nabel E. G., Yang Z., Plautz G., Forough R., Zhan X., Haudenschild C. C., et al: Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in vivo. Nature 1993; 362: 844-846.
75. Lindner V., Majack R. A., Reidy M. A.: Basic fibroblast growth factor stimulates endothelial regrowth and proliferation in denuded arteries. J Clin Invest 1990; 85: 2004-2008.
76. Friedlander M., Brooks P. C., Shaffer R. W., Kincaid C. M., Var-ner J. A., Cheresh D. A.: Definition of 2 angiogenic pathways by distinct ffv integrins. Science 1995; 270: 1500-1502.
77. Folkman J., Klagsbrun M.: Angiogenic factors. Science 1987; 235: 442-447.
78. Shapiro R., Riordan J. F., Vallee B. L.: Characteristic ribonu-cleolytic activity of human angiogenin. Biochemistry 1986; 25: 3527-3532.
79. Liaw L., Almeida M., Hart C. E., Schwartz S. M., Giachelli C. M.: Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res 1994; 74: 214-224.
80. Liaw L., Lindner V., Schwartz S. M., Chambers A. F., Giachelli C. M.: Osteopontin and β3 integrin are coordinately expressed in regenerating endothelium in vivo and stimulate Arg-Gly-Asp-dependent endothelial migration in vitro. Circ Res 1995; 77: 665-672.
81. Garvin M. R., Labinaz M., Pels K., Hoffert C., O'Brien E. R.: Osteopontin (OPN) in organizing thrombus after balloon injury: Potential role in cell migration and neovascularization (abstract). Can J Cardiol 1996; 12: 148E
82. Morales D. E., McGowan K. A., Grant D. S., Maheshwari S., Bhartiya D., Cid M. C., et al: Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 1995; 91: 755-763.
83. Cullinan-Bove K., Koos R. D.: Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 1993; 133: 829-837.
84. Koch A. E., Polverini P. J., Kunkel S. L., Harlow L. A., DiPietro L. A., Elner V. M., et al: Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258: 1798-1801.
85. Koch A. E., Cho M., Burrows J. C., Polverini P. J., Leibovich S. J.: Inhibition of production of monocyte/macrophage-derived angiogenic activity by oxygen free-radical scavengers. Cell BiolInt Rep 1992; 16: 415-425.
86. Arenberg D. A., Kunkel S. L., Polverini P. J., Glass M., Burdick M. D., Strieter R. M.: Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996; 97: 2792-2802.
87. Nickoloff B. J., Mitra R. S., Varani J., Dixit V. M., Polverini P. J.: Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes mediates angiogenesis. Am J Pathol 1994; 144:820-828.
88. Pepper M. S., Cassalli J. K., Montesano R., Orci L.: Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 1987; 105: 2535-2541.
89. Schnaper H. W., Barnathan E. S., Mazar A., Maheshwari S., Ellis S., Cortez S. L., et al: Plasminogen activators augment endothelial cell organization in vitro by 2 distinct pathways. J Cell Physiol 1995; 165: 107-118.
90. Mignatti P., Rifkin D. B.: Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 1996; 49: 117-137.
91. Saksela O., Rifkin D. B.: Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 1990; 110: 767-775.
92. Falcone D. J., McCaffrey T. A., Haimovitz-Friedman A., Ver-gilio J. A., Nicholson A. C.: Macrophage and foam cell release of matrix-bound growth factors. J Biol Chem 1993; 268: 11951-11958.
93. Frater-Schroder M., Risau W., Hallmann R., Gautsch P.: Tumor necrosis factor type a., a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987; 84: 5277-5281.
94. Leibovich S. J., Polverini P. J., Shephard H. M., Wiseman D. M., Shively V., Nuseir N.: Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α. Nature 1987; 329: 630-632.
95. Fajardo L. F., Kwan H. H., Kowalski J., Prionas S. D., Allison A. C.: Dual role of tumor necrosis factor α in angiogenesis. Am J Pathol 1992; 3: 539-544.
96. Koolwijk P., van Erck M. G. M., de Vree W. J. A., Vermeer M. A., Weich H. A., Hanemaaijer R., et al: Cooperative effect of TNFα;, βFGF, and VEGF on the formation tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol 1996; 132: 1177-1188.
97. Patterson C., Perrella M. A., Endege W. O., Yoshizumi M., Lee M. E., Haber E.: Downregulation of vascular endothelial growth factor receptors by tumor necrosis factor- a in cultured human vascular endothelial cells. J Clin Invest 1996; 98: 490-496.
98. Heimark R. L., Twardzik D. R., Schwartz S. M.: Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. Science 1986; 233: 1078-1080.
99. Roberts A. B., Sporn M. B., Assoian R. K., Smith J. M., Roche N. S., Wakefield L. M., et al: Transforming growth factor type beta: Rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986; 83: 4167-4171.
100. Pepper M. S., Vassalli J.D., Orci L., Montesano R.: Biphasic effect of transforming growth factorβ1 on in vitro angiogenesis. Exp Cell Res 1993; 204: 356-363.
101. Fajardo L. F., Prionas S. D., Kwan H. H., Kowalski J., Allison A. C.: Transforming growth factor β1 induces angiogenesis in vivo with a threshold pattern. Lab Invest 1996; 74: 600-608.
102. Falcone D. J., McCaffrey T. A., Haimovitz-Friedman A., Garcia M.: Transforming growth factor-β1 stimulates macrophage urokinase expression and release of matrix-bound basic fibroblast growth factor. J Cell Physiol 1993; 155: 595-605.
103. Mandriota S. J., Menoud P. A., Pepper M. S.: Transforming growth factor β1 down-regulates vascular endothelial growth factor receptor β1 expression in vascular endothelial cells. J Biol Chem 1996; 271: 11500-11505.
104. Fong G. H., Rossant J., Gertsenstein M., Breitman M. L.: Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376: 66-70.
105. Plate K. H., Breier G., Weich H. A., Mennel H. D., Risau W.: Vascular endothelial growth factor and glioma angiogenesis: Coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. IntJ Cancer 1994; 59: 520-529.
106. Witzigmann-Voos S., Breier G., Risau W., Plate K. H.: Upregulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease associated and sporadic hemangioblastomas. Cancer Res 1995; 55: 1358-1364.
107. Peters K. G., De Vries C., Williams L. T.: Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc Natl Acad Sci USA 1993; 90: 8915-8919.
108. Yamaguchi T. P., Dumont D. J., Conlon R. A., Breitman M. L., Rossant J.: Flk-1, an fit-related receptor tyrosin kinase is an early marker for endothelial cell precursors. Development 1993; 118: 489-498.
109. Millauer B., Witzigmann-Voos S., Schnuerich H., Martinez R., Moller N. H., Risau W., et al: High affinity VEGF binding and developmental expression suggests flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835-846.
110. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C.H.: Different signal transduction properties of KDR and flt-1, 2 receptors for vascular endothelial growth factor. J Biol Chem 1994; 269: 26988-26995.
111. Shalaby F., Rossant J., Yamaguchi T., Gertsenstein M., Breitman M. L., Schuh A. C.: Failure of blood island formation and vasculogenesis in flk-1 deficient mice. Nature 1995; 376: 62-66.
112. Millauer B., Shawver L. K., Plate K. H., Risau W., Ullrich A.: Glioblastoma growth inhibited in vivo by a dominant-negative flk-1 mutant. Nature 1994; 367: 576-579.
113. Brogi E., Schatteman G., Wu T., Kim E. A., Varticovski L., Keyt B., et al: Hypoxia induced paracrine regulation of vascular endothelial growth factor receptor expression. J Clin Invest 1996; 97: 469-476.
114. Mustonen T., Alitalo K.: Endothelial receptor tyrosine kinases involved in angiogenesis. J Cell Biol 1995; 129: 895-898.
115. Korhonen J., Partanen J., Armstrong E., Vaahtokari A., Elenius K., Jalkanen M., et al: Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 1992; 80: 2548-2555.
116. Partanen J., Puri M. C., Schwartz L., Fischer K. D., Bernstein A., Rossant J.: Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development. Development 1996; 122: 3013-3021.
117. Sato T. N., Tozawa Y., Deutsch U., Wolburg-Buchholz K., Fujiwara Y., Gendron-maguire M., et al: Distinct roles of the receptor tyrosine kinases tie-1 and tie-2 in blood vessel formation. Nature 1995; 376: 70-74.
118. Puri M. C., Rossant J., Alitalo K., Bernstein A., Partanen J.: The receptor tyrosine kinase tie is required for integrity and survival of vascular endothelial cells. EMBO J 1995; 14: 5884-5891.
119. Dumont D. J., Gradwohl G. J., Fong G. H., Puri M. C., Gertsenstein M., Auerbach A., et al: Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 1994; 8: 1897-1909.
120. Johns A., Freay A. D., Fraser W., Korach K. S., Rubanyi G. M.: Disruption of estrogen receptor gene prevents 17β estradiol-induced angiogenesis in transgenic mice. Endocrinology 1996; 137:4511-4513.
121. Pepper M. S., Sappino A.P., Stoecklin R., Montesano R., Orci L., Vassalli J.D.: Upregulation of urokinase receptor expression on migrating endothelial cells. I Cell Biol 1993; 122: 673-684.
122. Mandriota S. J., Seghezzi G., Vassalli J.D., Ferrara N., Wasi S., Mazzieri R., et al: Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 1995; 270: 9709-9716.
123. Mignatti P., Mazzieri R., Rifkin D. B.: Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol 1991; 113: 1193-1201.
124. Yebra M., Parry G. C. N., Stromblad S., Mackman N., Rosenberg S., Mueller B. M., et al: Requirement of receptor-bound urokinase-type plasminogen activator for integrin αvβ5-directed cell migration. J Biol Chem 1996; 271: 29393-29399.
125. Drake C. J., Cheresh D. A., Little C. D.: An antagonist of integrin αvβ3 prevents maturation of blood vessel during embryonic neovascularization. J Cell Sci 1995; 108: 2655-2661.
126. Brooks P. C., Clark R. A. F., Cheresh D. A.: Requirement of vascular integrin αvβ3 for angiogenesis. Science 1994; 264: 569-571.
127. Brooks P. C., Montgomery A. M. P., Rosenfeld M., Reisfeld R. A., Hu T., Klier G., et al: Integrin αvβ3 antagonists promote further tumor regression by inducing apoptosis of angiogenic bloodvessels. Cell 1994; 79: 1157-1164.
128. Luna J., Tobe T., Mousa S. A., Reilly T. M., Campochiaro P. A.: Antagonists of integrin αvβ3 inhibit retinal neovascularization in a murine model. Lab Invest 1996; 75: 563-573.
129. Stîmblad S., Becker J. C., Yebra M., Brooks P. C., Cheresh D. A.: Suppression of p53 activity and p21WAFl/CIPl expression by vascular cell integrin αvβ3 during angiogenesis. J Clin Invest 1996; 98: 426-433.
130. Sepp N. T., Li L., Lee K. H., Brown E. J., Caughman S. W., Lawley T. J., et al: Basic fibroblast growth factor increases expression of the αvβ3 integrin complex on human microvascular endothelial cells. J Invest Dermatol 1994; 103: 295-299.
131. Clark R. A. F., Tonnesen M. G., Gailit J., Cheresh D. A.: Transient functional expression of avb3 on vascular cells during wound healing. Am J Pathol 1996; 148: 1407-1421.